Literature DB >> 18632610

A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1.

Denise M Piscopo1, Philip W Hinds.   

Abstract

Cyclin G1 was identified as a transcriptional target of p53 that encodes a protein with strong homology to the cyclin family of cell cycle regulators. We show that either ectopically expressed or endogenous cyclin G1 protein is very unstable, undergoes modification with ubiquitin, and is likely degraded by the proteasome. Ectopic cyclin G1 protein stability is increased by cyclin box mutation or by association with inactive cyclin-dependent kinase (CDK) subunits, suggesting that a function of cyclin G1 as a CDK regulator may be required for its rapid turnover. Furthermore, cyclin G1 and the cyclin box mutant interact with and are ubiquitinated by MDM2, another transcriptional target of p53 that acts as a negative regulator of p53 stability. These data suggest that the cyclin box has a role in the proteasome-mediated degradation of cyclin G1 and thus suggest a putative role for a CDK in cyclin G1 metabolism and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632610      PMCID: PMC2518098          DOI: 10.1158/0008-5472.CAN-07-6346

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

2.  p53-dependent association between cyclin G and the B' subunit of protein phosphatase 2A.

Authors:  K Okamoto; C Kamibayashi; M Serrano; C Prives; M C Mumby; D Beach
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

3.  The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity.

Authors:  M L Smith; H U Kontny; R Bortnick; A J Fornace
Journal:  Exp Cell Res       Date:  1997-01-10       Impact factor: 3.905

4.  A Cdc28 mutant uncouples G1 cyclin phosphorylation and ubiquitination from G1 cyclin proteolysis.

Authors:  E Ceccarelli; C Mann
Journal:  J Biol Chem       Date:  2001-08-29       Impact factor: 5.157

5.  Reduced hepatic tumor incidence in cyclin G1-deficient mice.

Authors:  Michael Rugaard Jensen; Valentina M Factor; Anna Fantozzi; Kristian Helin; Chang-Goo Huh; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest.

Authors:  David A Bennin; Aruni S Arachchige Don; Tiffany Brake; Jennifer L McKenzie; Heidi Rosenbaum; Linette Ortiz; Anna A DePaoli-Roach; Mary C Horne
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

7.  MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.

Authors:  Z K Yu; R K Geyer; C G Maki
Journal:  Oncogene       Date:  2000-11-30       Impact factor: 9.867

Review 8.  Functions of the MDM2 oncoprotein.

Authors:  D A Freedman; L Wu; A J Levine
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

9.  Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein.

Authors:  Shinya H Kimura; Hiroshi Nojima
Journal:  Genes Cells       Date:  2002-08       Impact factor: 1.891

10.  Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1.

Authors:  K Tamura; Y Kanaoka; S Jinno; A Nagata; Y Ogiso; K Shimizu; T Hayakawa; H Nojima; H Okayama
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

View more
  11 in total

1.  SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.

Authors:  Mukul K Mittal; Kshipra Singh; Smita Misra; Gautam Chaudhuri
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

2.  Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.

Authors:  Guangyan Liu; Xiancai Ma; Zhe Wang; Kousho Wakae; Yaochang Yuan; Zhangping He; Hironori Yoshiyama; Hisashi Iizasa; Hui Zhang; Mami Matsuda; Ryuichi Sugiyama; Zhiyu Yuan; Masamichi Muramatsu; Linghua Li
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

3.  Cyclin I is involved in the regulation of cell cycle progression.

Authors:  Taiki Nagano; Toshiaki Hashimoto; Akio Nakashima; Shin-ichi Hisanaga; Ushio Kikkawa; Shinji Kamada
Journal:  Cell Cycle       Date:  2013-07-11       Impact factor: 4.534

4.  The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Authors:  Lifei Jiang; Rong Liu; Yingying Wang; Chunmiao Li; Qinghua Xi; Jianxin Zhong; Jian Liu; Shuyun Yang; Juan Wang; Menghui Huang; Chunhui Tang; Zheng Fang
Journal:  J Mol Histol       Date:  2015-05-17       Impact factor: 2.611

5.  ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53.

Authors:  S Ohno; Y Naito; S Mukai; N Yabuta; H Nojima
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

6.  Evolutionary change driven by metal exposure as revealed by coding SNP genome scan in wild yellow perch (Perca flavescens).

Authors:  Sébastien Bélanger-Deschênes; Patrice Couture; Peter G C Campbell; Louis Bernatchez
Journal:  Ecotoxicology       Date:  2013-05-31       Impact factor: 2.823

7.  GW8510 increases insulin expression in pancreatic alpha cells through activation of p53 transcriptional activity.

Authors:  Dina Fomina-Yadlin; Stefan Kubicek; Amedeo Vetere; Kai Hui Hu He; Kaihui Hu He; Stuart L Schreiber; Bridget K Wagner
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

8.  Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2.

Authors:  Shouichi Ohno; Jun-Ichiro Ikeda; Yoko Naito; Daisuke Okuzaki; Towa Sasakura; Kohshiro Fukushima; Yukihiro Nishikawa; Kaori Ota; Yorika Kato; Mian Wang; Kosuke Torigata; Takashi Kasama; Toshihiro Uchihashi; Daisaku Miura; Norikazu Yabuta; Eiichi Morii; Hiroshi Nojima
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

9.  CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.

Authors:  Ying Xu; Qing Zhang; Chunying Miao; Samina Dongol; Yinuo Li; Chenjuan Jin; Ruifeng Dong; Yingwei Li; Xingsheng Yang; Beihua Kong
Journal:  Cancer Med       Date:  2018-12-18       Impact factor: 4.452

10.  Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists.

Authors:  Erlinda M Gordon; Joshua R Ravicz; Seiya Liu; Sant P Chawla; Frederick L Hall
Journal:  Mol Clin Oncol       Date:  2018-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.